期刊
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
卷 19, 期 9, 页码 2232-2243出版社
WILEY
DOI: 10.1111/jcmm.12610
关键词
adipose tissue derived MSCs; melatonin; myocardial infarction; reactive oxygen species; rat model; apoptosis; viability; therapeutic strategy
资金
- National Natural Science Foundation of China [8135002]
- Clinical Support Foundation of Chinese PLA General Hospital [2012FC-TSYS-2004, 2013FC-TSYS-2015]
- Central Health Special Research Projects [13BJZ26]
Myocardial infarction (MI) is a major cause of death and disability worldwide. In the last decade, mesenchymal stem cells (MSCs) based cell therapy has emerged as a promising therapeutic strategy. Although great advance have been made using MSCs to treat MI, the low viability of transplanted MSCs severely limits the efficiency of MSCs therapy. Here, we show evidence that exvivo pre-treatment with melatonin, an endogenous hormone with newly found anti-oxidative activity, could improve survival and function of adipose tissue derived MSCs (ADSCs) invitro as well as invivo. ADSCs with 5M melatonin pre-treatment for 24hrs showed increased expression of the antioxidant enzyme catalase and Cu/Zn superoxide dismutase (SOD-1), as well as pro-angiogenic and mitogenic factors like insulin-like growth factor 1, basic fibroblast growth factor, hepatocyte growth factor (HGF), epidermal growth factor. Furthermore, melatonin pre-treatment protected MSCs from reactive oxygen species (ROS) induced apoptosis both directly by promoting anti-apoptosis kinases like p-Akt as well as blocking caspase cascade, and indirectly by restoring the ROS impaired cell adhesion. Using a rat model of MI, we found that melatonin pre-treatment enhanced the viability of engrafted ADSCs, and promoted their therapeutic potency. Hopefully, our results may shed light on the design of more effective therapeutic strategies treating MI by MSCs in clinic.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据